Undenatured Type II Collagen: UC-II, Dose, and Label Guide

Type II collagen is a major structural collagen in cartilage. In supplements, however, the words beside that name matter as much as the type number. Native or undenatured preparations are processed to retain more of the protein’s original structure and are usually sold in milligram amounts. Hydrolyzed collagen has been broken into smaller peptides and is usually sold in gram amounts.

Undenatured type II products are commonly positioned for joint comfort or mobility. Their proposed oral-tolerance pathway is a mechanistic explanation, not evidence that swallowed collagen travels intact to a joint or rebuilds cartilage. Human evidence must be tied to the exact preparation, dose, population, comparator, and outcome that were studied. ^{1, 2}

Labels use native, undenatured, non-denatured, and nondenatured for preparations intended to retain type II collagen structure. These terms can point to the same broad category, but they do not establish identical manufacturing, composition, or clinical equivalence.

UC-II is a trademarked standardized chicken-cartilage ingredient used in several published trials. A generic undenatured type II collagen can still be a legitimate ingredient, but it should not inherit UC-II study results solely because the front label uses a similar category name. ^{1, 4}

Collagen Peptides are hydrolyzed fragments and are commonly measured in grams. Native or undenatured type II collagen is a separate low-dose category commonly measured in milligrams. A 40 mg undenatured product is not simply a smaller serving of a 5 g peptide powder, and the larger gram number does not make the peptide product a stronger version of UC-II.

The parent Collagen guide explains the broader category. For this page, the practical rule is to compare like with like: native preparation with native preparation, and hydrolyzed peptide preparation with hydrolyzed peptide evidence.

The frequently seen 40 mg UC-II amount refers to the branded standardized chicken-cartilage ingredient used in several trials. Some labels separately state a smaller amount of total or native collagen supplied by that material. Those figures describe different layers of the same ingredient and should not be added together. ^{1, 4}

Forty milligrams is not a universal target for every product. Human trials have also studied other native or undenatured preparations at 3.2 mg and 10 mg per day. Those amounts cannot be compared without knowing whether the number represents active undenatured collagen, a standardized cartilage material, or another preparation. ^{7, 8}

Randomized trials of specific native or undenatured type II products have reported improvements in selected knee osteoarthritis symptom scores and in some activity-related mobility outcomes. The evidence base is still limited by different preparations, modest samples, commercial involvement in many studies, and outcomes that are not uniformly positive. ^{1, 2, 4, 5, 6}

A 2025 trial of a combined product containing 40 mg undenatured type II collagen plus 960 mg hydrolyzed collagen found no significant advantage over placebo for pain, KOOS scores, rescue medication, or satisfaction after 12 weeks. Because two collagen forms were combined, it cannot isolate either ingredient, but it is important counterweight to a one-sided success narrative. ³

A 2026 randomized trial in 74 healthy adults found no between-group difference in time to pain onset across the standardized exercise tests. A difference in recovery time appeared for one of three exercise tests, while some KOOS and CTX-II differences emerged in preplanned subgroup analyses. The authors also noted a strong placebo response, population heterogeneity, and no multiplicity correction. That supports cautious, outcome-specific interpretation rather than a blanket joint-health claim. ⁶

A clean comparison needs the complete Supplement Facts line and any qualifiers immediately below it. Front-label phrases such as “clinically studied”, “ native” or “cartilage support” are incomplete without the named preparation, full-serving amount, source, and blend context.

Joint formulas can combine undenatured type II collagen with Glucosamine, Chondroitin, hyaluronic acid, Boswellia, or hydrolyzed collagen. Each ingredient needs its own disclosed amount and evidence context. A total joint-blend weight cannot be divided into plausible individual doses.

Many studied native or undenatured type II preparations are derived from chicken sternum cartilage. That source can matter for allergy, dietary, religious, or personal-preference reasons. A front label saying only “collagen” may not make the source obvious, so inspect the Supplement Facts panel, allergen statement, and other ingredient list.

Published trials generally reported similar adverse-event patterns between study groups, but modest trials cannot rule out rare reactions or establish universal long-term safety. There is no formal tolerable upper intake level specific to undenatured type II collagen, and the commonly studied 40 mg preparation amount is not an upper limit or a personal dose target. ^{1, 2, 6}

Pregnancy and breastfeeding data are limited. People with a relevant animal-source allergy or a significant health condition should review the complete product with a qualified clinician. Persistent or worsening joint symptoms also deserve assessment rather than being managed from a supplement label alone.